BD treats first subject in trial of bioabsorbable scaffold

BD treats first subject in trial of bioabsorbable scaffold

BD treated the first subject in the trial with GalaFLEX LITE Scaffold for reducing the recurrence of CC during breast revision surgeries.The post BD treats first subject in trial of bioabsorbable scaffold appeared first on Medical Device Network.

BD Begins Clinical Trial for GalaFLEX LITE Scaffold in Breast Revision Surgery

BD begins a clinical trial to evaluate GalaFLEX LITE Scaffold for reducing capsular contracture in breast revision surgery, aiming for FDA approval. BD (Becton, Dickinson and Company), a global medical technology company, announced the first patient treated in an Investigational Device Exemption (IDE) clinical trial intended to advance BD’s efforts to achieve Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the use o…